Deepika Rajesh

This inventor holds 17 USPTO granted patents and 9 published patent applications, plus 6 CIPO patents and 12 EPO patents. Top assignees: Fujifilm Cellular Dynamics, Inc., Cellular Dynamics International, Inc., Fujifilm Holdings America Corporation. Active years: 2006-2026.

USPTO Granted Patents = 17 (Patent Applications = 9)

% Patents Active = 94.1

CIPO Patents = 6 (Patent Applications = 11)

EPO Patents = 12 (Patent Applications = 21)

Average Co-Inventor Count = 3.7

ph-index = 7

Forward Citations = 138(Granted Patents)

Company Filing History:

9 out of 23

Fujifilm Cellular Dynamics, Inc.

patents

7 out of 29

Cellular Dynamics International, Inc.

patents

1 out of 2

Fujifilm Holdings America Corporation

patents

4. 1 out of 4,234

Wisconsin Alumni Research Foundation

patents

where one patent can have more than one assignee

Years Active: 2006-2026

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12716058 - METHODS FOR DIRECTED DIFFERENTIATION OF PLURIPOTENT STEM CELLS TO HLA HOMOZYGOUS IMMUNE CELLS (2026-08-25),

2. 12492380 - Methods for the production of hepatocytes (2025-12-09),

3. 12163155 - Antigen-specific immune effector cells (2024-12-10),

4. 12129486 - Methods for directed differentiation of pluripotent stem cells to immune cells (2024-10-29),

5. 10961505 - Generating mature lineages from induced pluripotent stem cells with MECP2 disruption (2021-03-30),

6. 10947502 - Methods for directed differentiation of pluripotent stem cells to immune cells (2021-03-16),

7. 10865381 - Multi-lineage hematopoietic precursor cell production by genetic programming (2020-12-15),

8. 10266807 - Methods and compositions for culturing endoderm progenitor cells in suspension (2019-04-23),

9. 10221396 - Reprogramming T cells and hematopoietic cells (2019-03-05),

10. 10100282 - Differentiation of pluripotent cells (2018-10-16),

11. 9487752 - Priming of pluripotent stem cells for neural differentiation (2016-11-08),

12. 9347044 - Reprogramming T cells and hematopoietic cells (2016-05-24),

13. 8765470 - Reprogramming immortalized B-cells to induced pluripotent stem cells (2014-07-01),

14. 8741648 - Reprogramming T cells and hematopoietic cells (2014-06-03),

15. 8513012 - Method for production of mast cells from stem cells (2013-08-20),

Title: Deepika Rajesh: Innovator in Immunotherapy

Introduction

Deepika Rajesh is a prominent inventor based in Madison, WI (US). She has made significant contributions to the field of immunotherapy, holding a total of 15 patents. Her work focuses on the development of advanced methods for producing immune cells from pluripotent stem cells.

Latest Patents

Among her latest patents is a groundbreaking method for the production of antigen-specific immune effector cells. This patent outlines techniques for generating effector T cells and NK cells that express a chimeric antigen receptor (CAR). Additionally, she has developed methods for adoptive cell therapy, which involves administering these effector T cells and/or NK cells for therapeutic purposes. Another notable patent details the directed differentiation of pluripotent stem cells into immune cells. This innovation allows for the efficient in vitro differentiation of somatic cell-derived pluripotent stem cells into hematopoietic precursor cells, which can further differentiate into various immune cell lineages, including T cells, NK cells, and dendritic cells.

Career Highlights

Deepika has worked with notable companies such as Fujifilm Cellular Dynamics, Inc. and Cellular Dynamics International, Inc. Her experience in these organizations has contributed to her expertise in the field of cellular dynamics and immunotherapy.

Collaborations

Some of her coworkers include Sarah Burton and Amanda Mack, who have collaborated with her on various projects related to her patents and innovations.

Conclusion

Deepika Rajesh is a trailblazer in the field of immunotherapy, with a strong portfolio of patents that reflect her innovative spirit and dedication to advancing medical science. Her contributions are paving the way for new therapeutic approaches in the treatment of diseases.